Exclusive

Publication

Byline

Location

US Patent Issued to Vivasor on May 19 for "Antigen binding proteins that bind BCMA" (California Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,642, issued on May 19, was assigned to Vivasor Inc. (San Diego). "Antigen binding proteins that bind BCMA" was invented by Heyue Zhou (San D... Read More


US Patent Issued to STRIKE PHARMA on May 19 for "CD40 binding protein, bispecific conjugate thereof and method of treating cancer" (Swedish Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,643, issued on May 19, was assigned to STRIKE PHARMA AB (Lund, Sweden). "CD40 binding protein, bispecific conjugate thereof and method of tr... Read More


US Patent Issued to BIOINTRON BIOLOGICAL on May 19 for "Anti-CD40 single-domain antibody, and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,644, issued on May 19, was assigned to BIOINTRON BIOLOGICAL INC. (Shanghai). "Anti-CD40 single-domain antibody, and preparation method there... Read More


US Patent Issued to Miltenyi Biotec on May 19 for "Compositions and methods for treating cancer expressing CD90 and CD326" (German Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,645, issued on May 19, was assigned to Miltenyi Biotec B.V. & Co. KG (Bergisch Gladbach, Germany). "Compositions and methods for treating ca... Read More


US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The Children's Hospital of Philadelphia, The United States of America, as represented by the Secretary, Department of Health and Human Services on May 19 for "Chimeric antigen receptors targeting glypican-2" (California, Maryland, Pennsylvania Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,646, issued on May 19, was assigned to The Board of Trustees of the Leland Stanford Junior University (Palo Alto, Calif.), The Children's Hos... Read More


US Patent Issued to UCB BIOPHARMA on May 19 for "Antibodies against KLK5" (British Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,647, issued on May 19, was assigned to UCB BIOPHARMA SRL (Brussels). "Antibodies against KLK5" was invented by Neesha Dedi (Slough, Great Br... Read More


US Patent Issued to Medlmmune on May 19 for "Binding molecules specific for CD73 and uses thereof" (British, American Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,648, issued on May 19, was assigned to Medlmmune Ltd. (Cambridge, Great Britain). "Binding molecules specific for CD73 and uses thereof" was... Read More


US Patent Issued to The Research Foundation for The State University of New York on May 19 for "Compositions and methods for improving tumor penetration of tumor specific antibodies" (New York Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,649, issued on May 19, was assigned to The Research Foundation for The State University of New York (Amherst, N.Y.). "Compositions and metho... Read More


US Patent Issued to TigaTX on May 19 for "Engineered IgA antibodies and methods of use" (Dutch Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,650, issued on May 19, was assigned to TigaTX Inc. (Boston). "Engineered IgA antibodies and methods of use" was invented by Jeanette Henrica... Read More


US Patent Issued to Angitia on May 19 for "Anti-sclerostin constructs and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,651, issued on May 19, was assigned to Angitia Inc. Ltd. (Woodland Hills, Calif.). "Anti-sclerostin constructs and uses thereof" was invente... Read More